Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 408

1.

Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.

Shimabukuro-Vornhagen A, Schlößer HA, Gryschok L, Malcher J, Wennhold K, Garcia-Marquez M, Herbold T, Neuhaus LS, Becker HJ, Fiedler A, Scherwitz P, Koslowsky T, Hake R, Stippel DL, Hölscher AH, Eidt S, Hallek M, Theurich S, von Bergwelt-Baildon MS.

Oncotarget. 2014 May 9. [Epub ahead of print]

PMID:
25026291
[PubMed - as supplied by publisher]
Free Article
2.

Homozygous GNAS 393C-Allele Carriers with Locally Advanced Esophageal Cancer Fail to Benefit from Platinum-Based Preoperative Chemoradiotherapy.

Alakus H, Bollschweiler E, Hölscher AH, Warnecke-Eberz U, Frazer KA, Harismendy O, Lowy AM, Mönig SP, Eberz PM, Maus M, Drebber U, Siffert W, Metzger R.

Ann Surg Oncol. 2014 Jul 2. [Epub ahead of print]

PMID:
24986238
[PubMed - as supplied by publisher]
3.

Validation of 2-mm Tissue Microarray Technology in Gastric Cancer. Agreement of 2-mm TMAs and Full Sections for Glut-1 and Hif-1 Alpha.

Berlth F, Mönig SP, Schlösser HA, Maus M, Baltin CT, Urbanski A, Drebber U, Bollschweiler E, Hölscher AH, Alakus H.

Anticancer Res. 2014 Jul;34(7):3313-20.

PMID:
24982335
[PubMed - in process]
4.

What Should Be the Gold Standard for the Surgical Component in the Treatment of Locally Advanced Esophageal Cancer: Transthoracic Versus Transhiatal Esophagectomy.

Kutup A, Nentwich MF, Bollschweiler E, Bogoevski D, Izbicki JR, Hölscher AH.

Ann Surg. 2014 Jun 19. [Epub ahead of print]

PMID:
24950288
[PubMed - as supplied by publisher]
5.

Treatment of early gastric cancer in the Western World.

Bollschweiler E, Berlth F, Baltin C, Mönig S, Hölscher AH.

World J Gastroenterol. 2014 May 21;20(19):5672-8. doi: 10.3748/wjg.v20.i19.5672.

PMID:
24914327
[PubMed - in process]
Free PMC Article
6.

[Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer].

Fuchs HF, Hölscher AH.

Zentralbl Chir. 2014 Feb;139(1):32-6. doi: 10.1055/s-0033-1360295. Epub 2014 Feb 28. German.

PMID:
24585195
[PubMed - in process]
7.

[Quality of life and visceral surgery].

Bollschweiler E, Baltin C, Berlth F, Mönig SP, Hölscher AH.

Chirurg. 2014 Mar;85(3):203-7. doi: 10.1007/s00104-013-2602-0. German.

PMID:
24464336
[PubMed - in process]
8.

KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies.

Maus MK, Grimminger PP, Mack PC, Astrow SH, Stephens C, Zeger G, Hsiang J, Brabender J, Friedrich M, Alakus H, Hölscher AH, Lara P, Danenberg KD, Lenz HJ, Gandara DR.

Lung Cancer. 2014 Feb;83(2):163-7. doi: 10.1016/j.lungcan.2013.11.010. Epub 2013 Nov 21.

PMID:
24331409
[PubMed - in process]
9.

Second study on the recurrence risk of isolated esophageal atresia with or without trachea-esophageal fistula among first-degree relatives: no evidence for increased risk of recurrence of EA/TEF or for malformations of the VATER/VACTERL association spectrum.

Choinitzki V, Zwink N, Bartels E, Baudisch F, Boemers TM, Hölscher A, Turial S, Bachour H, Heydweiller A, Kurz R, Bartmann P, Pauly M, Brokmeier U, Leutner A, Nöthen MM, Schumacher J, Jenetzky E, Reutter H.

Birth Defects Res A Clin Mol Teratol. 2013 Dec;97(12):786-91. doi: 10.1002/bdra.23205. Epub 2013 Dec 5.

PMID:
24307608
[PubMed - in process]
10.

Reply to letter: "significance of lymphadenectomy in ypT0N0M0R0 esophageal cancer".

Hölscher AH, Bollschweiler E.

Ann Surg. 2014 Apr;259(4):e68. doi: 10.1097/SLA.0000000000000365. No abstract available.

PMID:
24253158
[PubMed - indexed for MEDLINE]
11.

[Prof. H. J. Meyer - new General Secretary of the German Society of Surgery].

Hölscher AH.

Zentralbl Chir. 2014 Apr;139(2):157. doi: 10.1055/s-0033-1350820. Epub 2013 Nov 15. German. No abstract available.

PMID:
24241951
[PubMed - in process]
12.

Extracapsular lymph node spread as a negative prognostic factor of adenocarcinoma of the pancreas and cancer of the papilla of vater.

Prenzel KL, Hölscher AH, Drebber U, Bollschweiler E, Gutschow CA, Stippel DL, Mönig SP.

Pancreas. 2014 Jan;43(1):64-8. doi: 10.1097/MPA.0b013e3182a44a91.

PMID:
24212239
[PubMed - in process]
13.

Frequency of lymph node metastasis in submucosal esophageal cancer.

Hölscher AH, Bollschweiler E.

Ann Surg. 2014 Jun;259(6):e84. doi: 10.1097/SLA.0000000000000298. No abstract available.

PMID:
24169170
[PubMed - indexed for MEDLINE]
14.

Management of upper intestinal leaks using an endoscopic vacuum-assisted closure system (E-VAC).

Bludau M, Hölscher AH, Herbold T, Leers JM, Gutschow C, Fuchs H, Schröder W.

Surg Endosc. 2014 Mar;28(3):896-901. doi: 10.1007/s00464-013-3244-5. Epub 2013 Oct 23.

PMID:
24149851
[PubMed - in process]
Free PMC Article
15.

Novel diagnostic and prognostic biomarkers in esophageal cancer.

Plum PS, Bollschweiler E, Hölscher AH, Warnecke-Eberz U.

Expert Opin Med Diagn. 2013 Nov;7(6):557-71. doi: 10.1517/17530059.2013.843526. Epub 2013 Oct 4. Review.

PMID:
24093836
[PubMed - indexed for MEDLINE]
16.

pT2 Adenocarcinoma of the esophagus: early or advanced cancer?

Metzger R, Lorenz D, Gockel I, Origer J, Plum PS, Junginger T, Drebber U, Hansen T, Krümpelmann K, Fisseler-Eckhoff A, Lang H, Hölscher AH, Bollschweiler E.

Ann Thorac Surg. 2013 Nov;96(5):1840-5. doi: 10.1016/j.athoracsur.2013.05.086. Epub 2013 Aug 27.

PMID:
23987902
[PubMed - indexed for MEDLINE]
17.

A prospective randomized controlled trial of semi-mechanical versus hand-sewn or circular stapled esophagogastrostomy for prevention of anastomotic stricture.

Fetzner UK, Hölscher AH.

World J Surg. 2013 Sep;37(9):2246-7. doi: 10.1007/s00268-013-2110-x. No abstract available.

PMID:
23736985
[PubMed - indexed for MEDLINE]
18.

Reply to letter: "For patients with early esophageal cancer endoscopic mucosa resection is not the end of the story!".

Pech O, Manner H, Ell C, Bollschweiler E, Hölscher AH.

Ann Surg. 2013 Jun;257(6):e22-3. doi: 10.1097/SLA.0b013e3182942dbe. No abstract available.

PMID:
23665975
[PubMed - indexed for MEDLINE]
19.

MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response.

Odenthal M, Bollschweiler E, Grimminger PP, Schröder W, Brabender J, Drebber U, Hölscher AH, Metzger R, Vallböhmer D.

Int J Cancer. 2013 Nov 15;133(10):2454-63. doi: 10.1002/ijc.28253. Epub 2013 Jun 3.

PMID:
23649428
[PubMed - indexed for MEDLINE]
20.

Prognostic relevance of nutritional status in patients with advanced esophageal cancer.

Bollschweiler E, Herbold T, Plum P, Hölscher AH.

Expert Rev Anticancer Ther. 2013 Mar;13(3):275-8. doi: 10.1586/era.12.176.

PMID:
23477514
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk